SYNCELL

Taipei, Taiwan Founded: 2020 • Age: 6 yrs
Microscopic systems for protein and biomarker identification are developed.
Annual revenue - Latest available
Total funding $15.0M 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About SYNCELL

SYNCELL is a company based in Taipei (Taiwan) founded in 2020 by Jung Chi Liao. SYNCELL has raised $15 million across 1 funding round from investors including Taiwania Capital. SYNCELL offers products and services including Microscoop and Reagent Kits. SYNCELL operates in a competitive market with competitors including Nearfield Instruments, Delmic B.V, FlowVIEW Tek, Tiny Bright Things and Envue, among others.

  • Headquarter Taipei, Taiwan
  • Founders Jung Chi Liao
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Syncell Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $15 M (USD)

    in 1 rounds

  • Latest Funding Round
    $15 M (USD), Series A

    Dec 11, 2024

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SYNCELL

SYNCELL offers a comprehensive portfolio of products and services, including Microscoop and Reagent Kits.

Product name locked
Category locked
Primary

Enables high-precision proteomic discovery at cellular and subcellular levels.

Product name locked
Category locked
Locked

Optimized kits for spatial protein purification and integration with platforms.

People of SYNCELL

Headcount 10-50
Employee Profiles 13
Employee Profiles
People
Nikhil Rao
Chief Commercial Officer (cco)
People
Mario Scheel-Werner
Director Business Development / Head Of Sales EMEA
People
Michelli Faria de Oliveira
Sr. Applications Manager
People
Jennie Wu
Marketing Communication Assistant Manager

Unlock access to complete

Funding Insights of SYNCELL

SYNCELL has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in SYNCELL

SYNCELL has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Taiwania Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
VC firm focusing on technology companies
Locked Locked Locked
Premium access

Investor details for SYNCELL

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SYNCELL

Investments
Premium access

Investment portfolio details for SYNCELL

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - SYNCELL

Premium access

Detailed financials for SYNCELL

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Syncell Comparisons

SYNCELL Primary company
Description
Microscopic systems for protein and biomarker identification...
Location
Taipei, Taiwan
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for SYNCELL

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of SYNCELL

SYNCELL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nearfield Instruments, Delmic B.V., FlowVIEW Tek, Tiny Bright Things and Envue, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
High-throughput atomic force microscopy systems for 3D metrology are developed.
Locked Locked Locked
Provider of light and electron microscopy solutions for life sciences and materials science
Locked Locked Locked
Liquid monitoring, analysis, and particle detection systems are provided.
Locked Locked Locked
Microscopy tools for nanoscale imaging and measurement are provided.
Locked Locked Locked
Nanofluidic scattering microscopy technology for biomolecule imaging is provided.
Premium access

Detailed competitors of SYNCELL

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Syncell

Premium access

Complete news archive for SYNCELL

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SYNCELL

SYNCELL was founded in 2020 and raised its 1st funding round 4 years after it was founded.

SYNCELL is headquartered in Taipei, Taiwan.

Jung Chi Liao is the current CEO of SYNCELL. They have also founded this company.

SYNCELL is a funded company, having raised a total of $15M across 1 funding round to date.

SYNCELL was founded in 2020 in Taipei, Taiwan, within the biotechnology sector. A microscopic platform called Microscoop is developed for identifying and quantifying proteins and biomarkers. Proprietary optoproteomics technology is employed, along with automated AI-based recognition algorithms and photochemical labeling reagents. These tools support discovery research and investigations into disease mechanisms, focusing on novel protein analysis.

SYNCELL's top competitors include Nearfield Instruments, Delmic B.V. and Fluid Imaging Technologies.

SYNCELL offers Microscoop and Reagent Kits.

SYNCELL has 1 investor. Key investors include Taiwania Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available